These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 29596798

  • 21. Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway.
    Wang YJ, Ren QG, Gong WG, Wu D, Tang X, Li XL, Wu FF, Bai F, Xu L, Zhang ZJ.
    Oncotarget; 2016 Mar 22; 7(12):13328-39. PubMed ID: 26950279
    [Abstract] [Full Text] [Related]

  • 22. Protective effects of erythropoietin on tau phosphorylation induced by beta-amyloid.
    Sun ZK, Yang HQ, Pan J, Zhen H, Wang ZQ, Chen SD, Ding JQ.
    J Neurosci Res; 2008 Oct 22; 86(13):3018-27. PubMed ID: 18512763
    [Abstract] [Full Text] [Related]

  • 23. [Role of PI3K/Akt pathway in effect of paeoniflorin against Aβ25-35-induced PC12 cell injury].
    Liu L, Wang SY, Wang JG.
    Zhongguo Zhong Yao Za Zhi; 2014 Oct 22; 39(20):4045-9. PubMed ID: 25751960
    [Abstract] [Full Text] [Related]

  • 24. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
    Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S.
    J Ethnopharmacol; 2011 Feb 16; 133(3):1109-16. PubMed ID: 21129477
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway.
    Huang HC, Tang D, Xu K, Jiang ZF.
    J Recept Signal Transduct Res; 2014 Feb 16; 34(1):26-37. PubMed ID: 24188406
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The melatonin-N,N-dibenzyl(N-methyl)amine hybrid ITH91/IQM157 affords neuroprotection in an in vitro Alzheimer's model via hemo-oxygenase-1 induction.
    Buendia I, Egea J, Parada E, Navarro E, León R, Rodríguez-Franco MI, López MG.
    ACS Chem Neurosci; 2015 Feb 18; 6(2):288-96. PubMed ID: 25393881
    [Abstract] [Full Text] [Related]

  • 29. Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid-induced tau phosphorylation.
    Das V, Miller JH.
    Eur J Neurosci; 2012 Jun 18; 35(11):1705-17. PubMed ID: 22594877
    [Abstract] [Full Text] [Related]

  • 30. Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells.
    Shen XY, Luo T, Li S, Ting OY, He F, Xu J, Wang HQ.
    Int J Mol Med; 2018 Feb 18; 41(2):1138-1146. PubMed ID: 29207020
    [Abstract] [Full Text] [Related]

  • 31. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
    Chou CH, Yang CR.
    Int J Mol Sci; 2021 May 19; 22(10):. PubMed ID: 34069531
    [Abstract] [Full Text] [Related]

  • 32. A hypothetic role of minocycline as a neuroprotective agent against methylphenidate-induced neuronal mitochondrial dysfunction and tau protein hyper-phosphorylation: Possible role of PI3/Akt/GSK3β signaling pathway.
    Salehi P, Shahmirzadi ZY, Mirrezaei FS, Shirvani Boushehri F, Mayahi F, Songhori M, Abofazeli M, Motaghinejad M, Safari S.
    Med Hypotheses; 2019 Jul 19; 128():6-10. PubMed ID: 31203911
    [Abstract] [Full Text] [Related]

  • 33. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH, Zhang Y, Hong XY, Zhang JF, Wang JZ, Liu GP.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun 19; 37(3):307-312. PubMed ID: 28585125
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cryptotanshinone Attenuates Amyloid-β42-induced Tau Phosphorylation by Regulating PI3K/Akt/GSK3β Pathway in HT22 Cells.
    Lyu D, Jia J.
    Mol Neurobiol; 2022 Jul 19; 59(7):4488-4500. PubMed ID: 35575872
    [Abstract] [Full Text] [Related]

  • 36. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S, An FM, Yin L, Liu AR, Yin DK, Yao WB, Gao XD.
    Neuroscience; 2014 Jan 03; 256():137-46. PubMed ID: 24183963
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H, Bian W, Lin X, Ma Z, Chen W, Pu Y.
    Neurochem Res; 2016 Sep 03; 41(9):2470-80. PubMed ID: 27255602
    [Abstract] [Full Text] [Related]

  • 39. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
    Zhang Y, Zhang J, Wang E, Qian W, Fan Y, Feng Y, Yin H, Li Y, Wang Y, Yuan T.
    Toxicol Sci; 2018 Apr 01; 162(2):475-487. PubMed ID: 29228318
    [Abstract] [Full Text] [Related]

  • 40. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W, Liu X, Tian L, Gao Y, Liu W, Chen H, Jiang X, Xu Z, Ding H, Zhao Q.
    Eur J Med Chem; 2021 Oct 15; 222():113554. PubMed ID: 34098466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.